Diabetes mellitus, Hemostatic Hyperfunction, and Glycemic Control

Thromb Haemost 1995; 73(01): 165-166
DOI: 10.1055/s-0038-1653745

Letter to the Editor

Schattauer GmbH Stuttgart

M H Rosove

Division of Hematology-Oncology, UCLA Department of Medicine, Los Angeles, CA, USA

References
1 Knöbl P, Schernthaner G, Schnack C, Pietschmann P, Proidl S, Prager R, Vukovich T. Haemostatic abnormalities persist despite glycaemic improvement by insulin therapy in lean type 2 diabetic patients. Thromb Haemost 1994; 71: 692-697
2 Vukovich TC, Schemthaner G, Knöbl PN, Hay U. The effect of near- normoglycaemic control on plasma factor VIII/von Willebrand factor and fibrin degradation products in insulin dependent diabetic patients. J Clin Endocrinol Metab 1989; 69: 84-89
3 Schernthaner G, Vukovich T, Knöbl P, Hay U, Müller M. The effect of near normoglycaemic control on plasma levels of coagulation factor VII and the anticoagulants protein C and S in insulin dependent diabetic patients. Brit J Haematol 1989; 73: 356-359
4 Jennings AM, Ford I, Murdoch S, Greaves M, Preston FE, Ward JD. The effects of diet and insulin therapy on coagulation factor VII, blood viscosity, and platelet release proteins in diabetic patients with secondary sulfonylurea failure. Diab Med 1990; 8: 346-353
5 Rosove MH, Frank HJ L, Harwig SS L. Plasma β-thromboglobulin, platelet factor 4, fibrinopeptide A, and other hemostatic functions during improved, short-term glycemic control in diabetes mellitus. Diab Care 1984; 7: 174-179